130 related articles for article (PubMed ID: 10909425)
1. 2-Thioether-5'-O-(1-thiotriphosphate)-adenosine derivatives: new insulin secretagogues acting through P2Y-receptors.
Fischer B; Shahar L; Chulkin A; Boyer JL; Harden KT; Gendron FP; Beaudoin AR; Chapal J; Hillaire-Buys D; Petit P
Isr Med Assoc J; 2000 Jul; 2 Suppl():92-8. PubMed ID: 10909425
[TBL] [Abstract][Full Text] [Related]
2. 2-thioether 5'-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-Receptors.
Fischer B; Chulkin A; Boyer JL; Harden KT; Gendron FP; Beaudoin AR; Chapal J; Hillaire-Buys D; Petit P
J Med Chem; 1999 Sep; 42(18):3636-46. PubMed ID: 10479295
[TBL] [Abstract][Full Text] [Related]
3. Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.
Fischer B; Boyer JL; Hoyle CH; Ziganshin AU; Brizzolara AL; Knight GE; Zimmet J; Burnstock G; Harden TK; Jacobson KA
J Med Chem; 1993 Nov; 36(24):3937-46. PubMed ID: 8254622
[TBL] [Abstract][Full Text] [Related]
4. Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists.
Nahum V; Zündorf G; Lévesque SA; Beaudoin AR; Reiser G; Fischer B
J Med Chem; 2002 Nov; 45(24):5384-96. PubMed ID: 12431066
[TBL] [Abstract][Full Text] [Related]
5. Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell.
Petit P; Hillaire-Buys D; Manteghetti M; Debrus S; Chapal J; Loubatières-Mariani MM
Br J Pharmacol; 1998 Nov; 125(6):1368-74. PubMed ID: 9863669
[TBL] [Abstract][Full Text] [Related]
6. P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues.
Farret A; Filhol R; Linck N; Manteghetti M; Vignon J; Gross R; Petit P
Pharm Res; 2006 Nov; 23(11):2665-71. PubMed ID: 17048117
[TBL] [Abstract][Full Text] [Related]
7. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
[TBL] [Abstract][Full Text] [Related]
8. Potent agonist action of 2-thioether derivatives of adenine nucleotides at adenylyl cyclase-linked P2Y-purinoceptors.
Boyer JL; O'Tuel JW; Fischer B; Jacobson KA; Harden TK
Br J Pharmacol; 1995 Nov; 116(6):2611-6. PubMed ID: 8590978
[TBL] [Abstract][Full Text] [Related]
9. Purinergic receptors on insulin-secreting cells.
Hillaire-Buys D; Chapal J; Bertrand G; Petit P; Loubatières-Mariani MM
Fundam Clin Pharmacol; 1994; 8(2):117-27. PubMed ID: 8020870
[TBL] [Abstract][Full Text] [Related]
10. Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 1. A synthetic, biochemical, and NMR approach.
Halbfinger E; Major DT; Ritzmann M; Ubl J; Reiser G; Boyer JL; Harden KT; Fischer B
J Med Chem; 1999 Dec; 42(26):5325-37. PubMed ID: 10639276
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of adenosine-5'-triphosphate and related analogues on insulin secretion from the rat pancreas.
Chapal J; Hillaire-Buys D; Bertrand G; Pujalte D; Petit P; Loubatières-Mariani MM
Fundam Clin Pharmacol; 1997; 11(6):537-45. PubMed ID: 9444521
[TBL] [Abstract][Full Text] [Related]
12. Irreversible activation of phospholipase C-coupled P2Y-purinergic receptors by 3'-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate.
Boyer JL; Harden TK
Mol Pharmacol; 1989 Dec; 36(6):831-5. PubMed ID: 2689859
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides.
Boyer JL; Downes CP; Harden TK
J Biol Chem; 1989 Jan; 264(2):884-90. PubMed ID: 2910869
[TBL] [Abstract][Full Text] [Related]
14. Effect of adenosine and phosphated derivatives on insulin release from the newborn dog pancreas.
Chapal J; Loubatières-Mariani MM; Roye M
J Physiol (Paris); 1981 Mar; 77(8):873-5. PubMed ID: 7042956
[TBL] [Abstract][Full Text] [Related]
15. Evidence for two different P2-purinoceptors on beta cell and pancreatic vascular bed.
Bertrand G; Chapal J; Loubatières-Mariani MM; Roye M
Br J Pharmacol; 1987 Aug; 91(4):783-7. PubMed ID: 3311264
[TBL] [Abstract][Full Text] [Related]
16. Adenosine-5'-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas.
Bertrand G; Chapal J; Puech R; Loubatières-Mariani MM
Br J Pharmacol; 1991 Mar; 102(3):627-30. PubMed ID: 1364829
[TBL] [Abstract][Full Text] [Related]
17. Sp-2-propylthio-ATP-α-B and Sp-2-propylthio-ATP-α-B,β-γ-dichloromethylene are novel potent and specific agonists of the human P2Y₁₁ receptor.
Haas M; Ben-Moshe I; Fischer B; Reiser G
Biochem Pharmacol; 2013 Sep; 86(5):645-55. PubMed ID: 23810430
[TBL] [Abstract][Full Text] [Related]
18. Novel modified adenosine 5'-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y(1) receptor: Biotinylated analogue potentially suitable for specific P2Y(1) receptor isolation.
Zündorf G; Schäfer R; Vöhringer C; Halbfinger E; Fischer B; Reiser G
Biochem Pharmacol; 2001 May; 61(10):1259-69. PubMed ID: 11322930
[TBL] [Abstract][Full Text] [Related]
19. Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen-activated protein kinase.
Albert JL; Boyle JP; Roberts JA; Challiss RA; Gubby SE; Boarder MR
Br J Pharmacol; 1997 Nov; 122(5):935-41. PubMed ID: 9384512
[TBL] [Abstract][Full Text] [Related]
20. Identification of potent P2Y-purinoceptor agonists that are derivatives of adenosine 5'-monophosphate.
Boyer JL; Siddiqi S; Fischer B; Romero-Avila T; Jacobson KA; Harden TK
Br J Pharmacol; 1996 Aug; 118(8):1959-64. PubMed ID: 8864529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
